Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion type Assertion NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_head.
- NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion description "[Twenty-three patients with B-cell non-immunoblastic lymphoma or follicular lymphoma who had a bcl-2 oncogene rearrangement had a poorer response to therapy (7 of 23 with complete remission) than the patients without bcl-2 rearrangement (21 of 26 with complete remission).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_provenance.
- NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion evidence source_evidence_literature NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_provenance.
- NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion SIO_000772 2648153 NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_provenance.
- NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion wasDerivedFrom befree-2016 NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_provenance.
- NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_assertion wasGeneratedBy ECO_0000203 NP1295080.RAHjhy4TI-ZaqblLC21SprMASFeFQ-WV0jfPLl_BdofwU130_provenance.